RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP (bleomycin, etoposide, and cisplatin) AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Etoposide
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 26 Jun 2013 Biomarkers information updated
- 15 Sep 2005 New trial record.